Theranostic Advances in Breast Cancer in Nuclear Medicine
Nasim Vahidfar, Ayuob Aghanejad, Hojjat Ahmadzadehfar, Saeed Farzanehfar, Elisabeth Eppard
Abstract
The implication of 'theranostic' refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.
Topics & Concepts
Breast cancerMedicineRadioligandMedical physicsCancerNuclear medicine imagingNuclear medicineInternal medicineReceptorRadiopharmaceutical Chemistry and ApplicationsPeptidase Inhibition and AnalysisHER2/EGFR in Cancer Research